LH

Labcorp Holdings Inc

NYSE

209.72

+0.23

+0.11%

Closed 17:41 07/25 EDT

OPEN

210.27

PREV CLOSE

209.49

HIGH

215.42

LOW

209.35

VOLUME

470.54K

TURNOVER

52 WEEK HIGH

234.09

52 WEEK LOW

191.97

MARKET CAP

17.68B

P/E (TTM)

42.38

Laboratory Corporation of America declares $0.72 dividend

Seeking Alpha · 1d ago

Labcorp Declares Quarterly Dividend

Labcorp declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 13, 2024. Labcorp is a global leader of innovative and comprehensive laboratory services. The company provided support for 84% of the new drugs and therapeutic products approved in 2023.

PR Newswire · 1d ago

Weekly Report: what happened at LH last week (0715-0719)?

Weekly Report · 4d ago

Investors Still Waiting For A Pull Back In Labcorp Holdings Inc. (NYSE:LH)

Labcorp Holdings Inc.'s price-to-earnings ratio of 44.6x is higher than the market in the United States. The company's earnings have been falling quicker than most other companies in recent years. Its superior growth outlook is contributing to its high P/E ratio. However, the company is expected to deliver strong growth over the next three years.

Simply Wall St · 6d ago

Labcorp, Quest among health firms to cite impact from CrowdStrike issue

Healthcare Labcorp, Quest among health firms to cite impact from CrowdStrike issue. Earlier in the day, a bug in CrowdStrike's software affected Microsoft users worldwide. The bug affected banks, airlines, TV stations, and supermarkets. LabcorP, Quest Diagnostics among major companies to acknowledge impact from the issue.

Seeking Alpha · 07/19 16:49

Strength Seen in Henry Schein (HSIC): Can Its 5.4% Jump Turn into More Strength?

NASDAQ · 07/18 07:33

Labcorp Workers In Washington Ratify A New Contract; Three-year Contract Includes Higher Wages For Every Position, & Elimination Of Ghost Steps

Benzinga · 07/17 20:41

Enzo Biochem: Is This Time Finally Different?

Enzo Biochem's stock is trading near historic lows. Stock has potential for attractive returns with simplified Life Sciences division and strong CEO incentives. Company has $35m in cash after sale of Clinical Labs business to Labcorp Holdings. New CEO has been granted calls with a strike at $2 a share. Valuation potential of $2.00-3.22/share with $75-120m business value.

Seeking Alpha · 07/17 04:49

About LH

Labcorp Holdings Inc. provides comprehensive laboratory services that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company serves clients in more than 100 countries.

Webull offers Labcorp Holdings Inc stock information, including NYSE: LH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LH stock methods without spending real money on the virtual paper trading platform.